Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis

Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis

Abstract Background African Americans are under-represented in trials evaluating oral anticoagulants for the treatment of acute venous thromboembolism (VTE). The aim of this study was to evaluate the effectiveness and safety of rivaroxaban versus warfarin for the treatment of VTE in African American...

Full description

Bibliographic Details
Main Authors: Olivia S. Costa, Stanley Thompson, Veronica Ashton, Michael Palladino, Thomas J. Bunz, Craig I. Coleman
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Thrombosis Journal
Subjects:
African Americans
Anticoagulants
Rivaroxaban
Venous thromboembolism
Warfarin
Online Access:http://link.springer.com/article/10.1186/s12959-020-00219-w

Internet

http://link.springer.com/article/10.1186/s12959-020-00219-w

Similar Items